Conditions: Diabetes Diabetes Mellitus, Type 2
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 343
Healthy volunteers: no

Brief summary:
This trial is conducted in Africa and Asia. The aim of the trial is to investigate the efficacy and safety of liraglutide versus sulphonylurea (SU) both in combination with metformin during Ramadan in subjects with type 2 diabetes (T2DM).

Detailed description:

Arms:
arm 1: Liraglutide 1.8 mg administered once daily subcutaneously, in combination with pre-trial tablet metformin of unchanged dose. arm 2: Subjects continued on pre-trial sulphonylurea tablet treatment, in combination with pre-trial tablet metformin of unchanged dose.

Interventions: intervention 1: liraglutide intervention 2: metformin intervention 3: sulphonylurea
Intervention descriptions: intervention 1: 1.8 mg administered subcutaneously (s.c., under the skin) once daily intervention 2: Subjects will continue on their pre-trial metformin tablet treatment, dose unchanged intervention 3: Subjects will continue on their pre-trial SU tablet treatment, doses unchanged

Protocol document: